Healthcare Startups in 2026: Where the Money Goes and Who’s Getting It
Healthcare startups raised $11.1B in the US in the first nine months of 2026. Who's getting funded, who pays them, and what founders should learn.

Healthcare startups are young companies selling products or services to patients, clinicians, hospitals, insurers, employers or drugmakers. In 2026 the money is flowing mostly to AI tools that sit inside clinical work: US digital health startups raised $11.1 billion in the first nine months of the year, according to Rock Health, and a small group of AI companies took a large share of it.
That concentration is the story. A handful of companies are raising at multibillion-dollar valuations while most founders in the sector find rounds slower and smaller. Here’s who’s winning, how they get paid, and what it means if you’re building one.
How much are healthcare startups raising?
Rock Health tracks venture funding for US digital health startups every quarter. Its numbers are the most widely cited benchmark for the sector, so they’re the ones I use.
| Period | Funding | Deals | Rock Health report |
|---|---|---|---|
| Full year 2024 | $10.5B | Not restated here | 2025 year-end overview (January 2026) |
| Full year 2025 | $14.2B | 482 | 2025 year-end overview (January 2026) |
| H1 2026 | $7.4B | 244 | H1 2026 overview (July 2026) |
| Q3 2026 | $3.7B | 114 | Q3 2026 market update (October 2026) |
| Jan to Sep 2026 | $11.1B | 358 (sum of the two rows above) | Q3 2026 market update |
Two details matter more than the totals. In 2025, AI-enabled companies took 54% of the money, up from 37% the year before, and Rock Health noted that removing the top nine companies by dollars raised would have pushed 2025 below 2024. In the first half of 2026, 20 rounds accounted for 45% of all funding.
My read: the headline recovery is real for the top tier. For a typical seed or Series A healthcare startup, the market still feels tight, and the bar is proof that customers pay, not proof that the product is clever.
Healthcare startups worth studying
I picked these because each shows a different way to get paid in healthcare, and each has dated, on-the-record numbers. Valuations are those set in the most recent reported round; private-company valuations are not market prices.
Abridge: AI scribe turned clinical platform
Abridge was cofounded in 2018 by cardiologist Shiv Rao. Its software listens to the patient-doctor conversation and drafts the clinical note, billing codes and patient summary.
According to Fortune (June 2026), Abridge has raised about $830 million, most recently a $316 million Series E extension in April 2026, at a $5.3 billion valuation. More than 300 health systems use it, and Eli Lilly made a strategic investment tied to clinical-trial screening.
Who pays: health systems.
The drawback: it’s a crowded fight. Microsoft owns Nuance, and Ambience, Suki and Nabla are well-funded rivals. Recording patient conversations also brings consent rules and liability if an AI-drafted note slips through unchecked.
OpenEvidence: the clinician’s search engine
OpenEvidence, cofounded by Daniel Nadler, answers clinicians’ questions using medical literature. CNBC reported in January 2026 that it raised $250 million led by Thrive Capital and DST Global at a $12 billion valuation, up from $1 billion in February 2025.
Who uses it: doctors directly, which let it spread by word of mouth instead of slow hospital procurement.
The drawback: general-purpose AI companies are moving into health questions, so it has to keep clinicians’ trust and keep its answers better than free alternatives.
Innovaccer: the data layer
Innovaccer, founded in 2014 with teams in the US and India, sells a healthcare data and AI platform to providers and payers. In January 2025 it announced a $275 million Series F, taking total funding to $675 million, with investors including Kaiser Permanente, Banner Health and M12. The company said more than 130 healthcare organizations use its platform.
Who pays: large health systems and insurers on enterprise contracts.
The drawback: long sales cycles and heavy integration work. It’s a reminder that Indian-founded health tech often wins by selling into the US market, a pattern you’ll see across the best startups in India.
Hinge Health and Omada: the exits that reopened the door
Hinge Health, which offers digital physical therapy, listed on the NYSE on May 22, 2025, pricing at $32 a share and raising about $437 million. Omada Health, a virtual chronic-care provider, followed on Nasdaq on June 6, 2025; Reuters reported its first-day trading valued it at $1.28 billion.
Who pays: mainly employers and health plans.
The lesson: public investors wanted revenue first. Hinge reported $432 million in revenue for the 12 months to March 2025 (Renaissance Capital). Healthcare rewards proof more than speed.
Who actually pays a healthcare startup?
In most industries the user pays. In healthcare, the user, the decision-maker and the payer are often three different people. Here’s how the companies above map out.
Four ways healthcare startups get paid, with the examples from this article.
Each buyer has a different sales cycle. Clinicians can adopt a tool in an afternoon. Health systems run security reviews and pilots. Employers buy on annual benefit cycles. Pick your buyer before you pick your features.
Why healthcare is harder than other startup markets
Regulation is part of the product. In the US, handling patient data brings HIPAA obligations and business associate agreements with your customers. Software that diagnoses or guides treatment may fall under FDA oversight. Budget for this from the first prototype, not after the first customer.
Evidence beats demos. Buyers want outcomes data: fewer readmissions, less clinician time on notes, lower claims costs. Plan a study, even a small one, early.
Rounds take longer. Because pilots and procurement are slow, healthcare startups often need more runway between rounds. If you’re aiming for a growth round, look at what Series B startups typically show investors and work backwards.
Some niches are crowded, some aren’t. Ambient scribing is now a knife fight. Behavioral health has its own dynamics, which I covered in my look at mental health tech companies.
If you’re starting a healthcare startup now
Start with a workflow problem that a specific buyer already spends money on. Talk to twenty people who’d sign the contract, not just the people who’d use the product. Get compliance advice before you touch real patient data.
Then aim for one paying customer whose results you can publish. In a market where 20 rounds take nearly half the money, a credible case study is what moves you from the long tail into the conversation.



Discussion